Acquisition of a new flow cytometer for advanced cell analysis
Official title: Acquisition of a FACSymphony S6 Sorter for the University of Toledo Flow Cytometry Core
Funded at University of Toledo Health Sci Campus · NIH-10854014 · Data updated 2026-11-12
This study is all about getting a new, high-tech machine to help researchers and students at the University of Toledo better analyze cells for their work in areas like immunology and molecular biology, making sure they have the best tools and support for their important research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Toledo Health Sci Campus NIH-funded |
| Lab location | 1 site (Toledo, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $350,000 |
| NIH project number | 1S10OD036266-01 |
| Project ID | NIH-10854014 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include researchers and graduate students involved in biomedical research at the University of Toledo.
✕Less likely to help
Patients who are not affiliated with the University of Toledo or who do not engage in research activities may not receive direct benefits from this research.
What this research studies
This research aims to acquire a state-of-the-art BD FACSymphony S6 flow cytometer to replace an outdated model at the University of Toledo's Flow Cytometry Core. The new equipment will enhance the capabilities of researchers and graduate students by providing access to advanced technology for analyzing cells in various biomedical fields, including immunology and molecular biology. The facility will offer training and consultation to ensure effective use of the new instrument, ultimately supporting ongoing and future research projects.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality and efficiency of cellular analysis for various biomedical studies.
How similar studies have gone: Similar research initiatives have successfully enhanced research capabilities at other institutions by upgrading core facilities with modern technology.
Where this research is happening
-
University of Toledo Health Sci Campus
Toledo, United States Active
Researchers
- Principal investigator: Kalinoski, Andrea Lynn — University of Toledo Health Sci Campus
- Study coordinator: Kalinoski, Andrea Lynn
Related research
Other NIH-funded projects on the same topics.
-
Understanding how ultra-potent opioids harm and how to reverse effects beyond traditional antidotes
Researchers are studying why some extremely strong synthetic opioids cause life-threatening effects and how to counter them, including situations where standard antidotes don’t work well.
-
Platform to Target and Degrade Disease-Causing Proteins
A new approach uses smart molecules to degrade harmful proteins that traditional drugs can’t touch, potentially benefiting people with diseases linked to those proteins.
-
Mitochondrial DNA and inflammation in back disc degeneration
A study to understand how damaged mitochondrial DNA may trigger inflammation and contribute to disc degeneration in adults.
-
Lyme disease vaccine research aimed at preventing infection
Researchers are developing a Lyme disease vaccine by studying how the immune system responds to Borrelia burgdorferi and testing vaccine approaches to prevent illness.
-
Dissecting how TNBC tumors suppress the immune system using myeloid cells
This NIH grant explores how a protein called TAZ helps triple-negative breast cancer evade the immune system, with the goal of improving treatments for patients with this aggressive cancer.
-
Exosome-based delivery to target pancreatic cancer cells
A patient-friendly look at a project that aims to use tiny natural vesicles to carry cancer-fighting therapies directly to pancreatic tumors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.